Diabetes mellitus, cardiovascular risk, and HIV disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed.

1. Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.HIV medicine · 2015
   Trial
2. Metabolic and redox pathway dysregulation in HIV-associated coronary endothelial dysfunction.American journal of physiology. Heart and circulatory physiology · 2026
   Observational
3. Metabolic and Redox Pathway Dysregulation in HIV-Associated Coronary Endothelial Dysfunction: Insights into Early-Phase HIV Vascular Dysfunction.bioRxiv : the preprint server for biology · 2025
   Article
4. Regional Differences in Added Sweetener Knowledge, Consumption and Body Mass Index in People with HIV in the United States.AIDS and behavior · 2023
   Article
5. The cause-effect relation of tuberculosis on incidence of diabetes mellitus.Frontiers in cellular and infection microbiology · 2023
   Review
6. Exploring the consequences of food insecurity and harnessing the power of peer navigation and mHealth to reduce food insecurity and cardiometabolic comorbidities among persons with HIV: protocol for development and implementation trial of weCare/Secure.Trials · 2022
   Article
7. [High incidence of asymptomatic myocardial ischemia in a population of HIV-infected patients in Bobo-Dioulasso, Burkina Faso].The Pan African medical journal · 2021
   Article
8. Cost-effectiveness analysis of integrating screening and treatment of selected non-communicable diseases into HIV/AIDS treatment in Uganda.Journal of the International AIDS Society · 2020
   Article
9. Low vitamin D is associated with coronary atherosclerosis in women with HIV.Antiviral therapy · 2019
   Article
10. Physical fitness characteristics of active duty US Air Force members with HIV infection.Medicine · 2016
    Article
11. Carotid artery thickness is associated with chronic use of highly active antiretroviral therapy in patients infected with human immunodeficiency virus: A 3.0 Tesla magnetic resonance imaging study.HIV medicine · 2016
    Article
12. Focusing National Institutes of Health HIV/AIDS research for maximum population impact.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015
    Article
13. Diabetes and HIV: current understanding and future perspectives.Current diabetes reports · 2013
    Review
14. Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy.European journal of epidemiology · 2012
    Article
15. The biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patients.The Journal of infectious diseases · 2012
    Review
16. A survey of the management, control, and complications of diabetes mellitus in patients attending a diabetes clinic in Blantyre, Malawi, an area of high HIV prevalence.The American journal of tropical medicine and hygiene · 2010
    Article
17. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy.AIDS (London, England) · 2009
    Article

Corrections and comments

• Comment on
  Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).2009

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as